Kraig Biocraft Laboratories (KBLB) Operating Income (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Operating Income across 15 years of filings, most recently posting $1.9 million for Q4 2025.

• Operating Income for Q4 2025 came in at $1.9 million, up 364.17% year-over-year; the trailing twelve-month figure through Dec 2025 was -$760904.0 (up 75.25% YoY), and the FY2025 annual result was -$760904.0, up 75.25% from the prior year.
• Operating Income came in at $1.9 million for Q4 2025 at Kraig Biocraft Laboratories, up from -$1.4 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of $1.9 million in Q4 2025 to a low of -$1.5 million in Q2 2024.
• The 5-year median for Operating Income is -$541189.0 (2022), against an average of -$566558.2.
• Peak annual rise in Operating Income reached 364.17% in 2025, while the deepest fall reached 238.34% in 2025.
• Kraig Biocraft Laboratories' Operating Income stood at -$516829.0 in 2021, then rose by 0.61% to -$513685.0 in 2022, then slumped by 131.29% to -$1.2 million in 2023, then jumped by 39.74% to -$715916.0 in 2024, then soared by 364.17% to $1.9 million in 2025.
• The last three Operating Income figures came in at $1.9 million (Q4 2025), -$1.4 million (Q3 2025), and -$637745.0 (Q2 2025), per Business Quant data.